Journal list menu
Export Citations
Download PDFs
Articles
Healthcare Providers' Perspectives on Antidepressant Discontinuation: A Focus Group Study
- First Published: 26 May 2025
Barriers and Facilitators to Pharmacist-Led Deprescribing of Antihypertensives in Long-Term Care: A Survey-Based Study
- First Published: 10 June 2025
Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia
- First Published: 02 June 2025
Montelukast Induces Depressive-Like Behaviour in ICR Young Mice Through Oxidative Stress and Inflammatory Response
- First Published: 10 April 2025
Foetal Exposure to Phthalates and Endocrine Effects on the Leydig Cell
- First Published: 09 April 2025
High Throughput Pharmacovigilance Screening for Roflumilast Adverse Effects in Real-World Settings: A Sequence Symmetry Analysis
- First Published: 21 April 2025
Traditional Chinese Medicine for Inhibiting Ferroptosis in Ischemic-Related Diseases
- First Published: 28 April 2025
Poisonings With Opioids and Benzodiazepines in Denmark: A Retrospective Study From the Danish Poison Information Centre
- First Published: 06 May 2025
TCA Cycle Intermediate Mitigates Di(2-ethylhexyl) Phthalate-Induced Cholestatic Liver Injury Through Modulation of the Nrf2/NQO1 Signalling Axis
- First Published: 15 May 2025
Acetaminophen in Pregnancy: A Population-Level Drug-Utilization Study of Prescription-Based Acetaminophen Use Among Pregnant Women in Denmark From 2001 to 2023
- First Published: 01 May 2025
Maternal Demographic Patterns in Medication use During Pregnancy: A Nationwide Register Study
- First Published: 18 March 2025
Baicalin Ameliorates L-Glutamate-Induced Hippocampal Oxidative Stress Injury and Apoptosis in Mice by Regulating Nrf2/HO-1 Signalling Pathway
- First Published: 20 March 2025
Advances in PET Imaging of α7 Nicotinic Receptors: From Radioligand Development to CNS Applications
- First Published: 14 March 2025
Ameliorative Role of β-Caryophyllene on Antioxidant Biomarkers in a Paroxetine-Induced Model of Male Sexual Dysfunction
- First Published: 17 February 2025
Could Flumazenil Be Used Pre-hospital by Intramuscular Injection for Coma due to Mixed Drug Overdose Not Responding to Naloxone?: A Systematic Review of the Evidence
- First Published: 13 February 2025
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder
- First Published: 01 February 2025
In Vivo Investigation of the Effects of Nonylphenol on the Pituitary–Adrenal Axis and Pineal Gland in Male Rats
- First Published: 31 January 2025

This study aimed to investigate the effect of nonylphenol on the pineal gland and melatonin, together with the pituitary–adrenal axis, which is associated with this system. Nonylphenol has adverse effects on the pituitary–adrenal axis, pineal gland, and melatonin tissues and hormones. Adverse effects have also been observed in liver and kidney tissues. Nonylphenol has a disruptive effect on the endocrine system.
Population pharmacokinetic modelling of cetirizine concentrations in human breast milk—A contribution from the ConcePTION project
- First Published: 04 November 2024
Diloxanide in amoebiasis management: Unravelling the mechanism of action and effectiveness
- First Published: 20 November 2024
Efflux and uptake transport and gut microbial reactivation of raloxifene glucuronides
- First Published: 19 December 2024

The enterohepatic recycling of raloxifene likely results from the interplay of gut microbial β-glucuronidases (GUS) and drug transporters expressed in the intestine and the liver. The efflux transporters MRP2 and MRP3 and the uptake transporters OATP1B1, OATP1B3 and OATP2B1 appear to mediate the transport of raloxifene glucuronides in enterocytes and hepatocytes. Gut microbial deglucuronidation of raloxifene glucuronides may represent an additional source of interindividual variability in raloxifene pharmacokinetics.